OpenAI sales leader James Dyett leaves for Thrive Capital role
James Dyett's move from OpenAI to Thrive Capital lands as the AI giant juggles a $852 billion valuation and visible leadership churn.

OpenAI lost another senior sales figure as James Dyett moved to Thrive Capital, a reminder that the battle around artificial intelligence is now being fought as much in enterprise contracts and capital allocation as in model development.
Dyett joined OpenAI in 2023, after ChatGPT had already turned the company into the defining name of the generative-AI boom. Over his time there, he worked on enterprise sales and API sales, two of the most commercially important lines in a company trying to turn technical dominance into durable revenue. His LinkedIn profile listed him as head of sales, while OpenAI described him as a senior sales leader.
The move takes Dyett to Thrive Capital, the New York venture firm founded by Joshua Kushner and known for software and internet investments. Thrive said Dyett will become an Operator in Residence, a role that suggests the firm wants someone who can translate operating experience into investment insight and back again. For a firm active across the startup ecosystem, the addition of a senior OpenAI sales executive fits a broader pattern in which investors are building closer ties to the companies shaping the AI stack.
Dyett said on X that the timing felt right to return to the early stages of company building and that OpenAI is in a strong place. Even so, his departure lands at a moment when OpenAI is under intense scrutiny from customers, rivals and investors alike. On March 31, the company said it closed a $122 billion funding round at a post-money valuation of $852 billion, calling itself core infrastructure for AI. That scale has made every executive change more consequential, because OpenAI is no longer simply a fast-growing startup but one of the most valuable private companies in the market.

The leadership picture has also become more visible in recent days. On April 3, OpenAI’s product and business chief, Fidji Simo, disclosed a significant medical leave tied to a worsening neuroimmune condition identified as POTS, and the company announced leadership changes in response. Dyett’s exit adds another name to that list and raises the question of whether the company’s rapid commercialization is pulling more talent toward investors, operators and dealmakers.
For OpenAI, the departure is not just about one sales leader. It highlights a larger power shift inside the AI economy, where the firms that can sell, finance and distribute the technology may matter almost as much as the labs that build it.
Know something we missed? Have a correction or additional information?
Submit a Tip

